Cyrille J. Cohen
Bar-Ilan University
H-index: 44
Asia-Israel
Top articles of Cyrille J. Cohen
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
11P Successful transfer and prolonged persistence of engineered lymphocytes with T-cell receptor targeting NY-ESO-1 | ESMO Open | J Arnon S Kein J Cohen A Zick Y Zarbiv | 2023/3/1 |
Feasibility of a novel academic anti-BCMA chimeric antigen receptor T-cell (CART)(HBI0101) for the treatment of relapsed and refractory AL amyloidosis | Blood | Eyal Lebel Shlomit Kfir-Erenfeld Nathalie Asherie Sigal Grisariu Batia Avni | 2023/11/28 |
Safety and Efficacy of a Locally Produced Novel Anti-BCMA Chimeric Antigen Receptor T-Cell (CART)(HBI0101) for the Treatment of Relapsed and Refractory Multiple Myeloma | Blood | Eyal Lebel Nathalie Asherie Shlomit Kfir-Erenfeld Batia Avni Sigal Grisariu | 2023/11/28 |
OA-34 Feasibility of a novel academic anti-BCMA chimeric antigen receptor T-cell (CART)(HBI0101) for the treatment of relapsed and refractory AL amyloidosis | Clinical Lymphoma Myeloma and Leukemia | Eyal Lebel Shlomit Kfir-erenfeld Nathalie Asherie Sigal Grisariu Batia Avni | 2023/9/1 |
P-026 Safety and efficacy of a locally produced novel anti-BCMA chimeric antigen receptor T-cell (CART)(HBI0101) for the treatment of relapsed and refractory multiple myeloma | Clinical Lymphoma Myeloma and Leukemia | Eyal Lebel Shlomit Kfir-erenfeld Nathalie Asherie Sigal Grisariu Batia Avni | 2023/9/1 |
Multifunctional nanoprobe for real-time in vivo monitoring of T cell activation | Nanomedicine: Nanotechnology, Biology and Medicine | Oshra Betzer Yue Gao Astar Shamul Menachem Motiei Tamar Sadan | 2022/11/1 |
Feasibility of a novel academic BCMA-CART (HBI0101) for the treatment of relapsed and refractory AL amyloidosis | Clinical Cancer Research | Shlomit Kfir-Erenfeld Nathalie Asherie Sigal Grisariu Batia Avni Eran Zimran | 2022/9/15 |
P887: IN-HOUSE ANTI BCMA CAR-T THERAPY FOR THE TREATMENT OF RELAPSED REFRACTORY MULTIPLE MYELOMA: PHASE 1 RESULTS. | HemaSphere | Nathalie Asherie Shlomit Kfir-Erenfeld Batia Avni Sigal Grisariu Miri Assayag | 2022/6 |
Adoptive T-cell Immunotherapy: Perfecting Self-Defenses | Raphaëlle Toledano Zur Galit Adler Katerina Shamalov Yair Tal Chen Ankri | 2022 | |
Downregulation of CD45 Signaling in COVID-19 Patients is reversed by C24D, a novel CD45 targeting peptide | Frontiers in Medicine | Danny Alon Yossi Paitan Eyal Robinson Nirit Ganor Julia Lipovetsky | 2021 |
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study | The Lancet | Noam Barda Noa Dagan Cyrille Cohen Miguel A Hernán Marc Lipsitch | 2021/12/4 |
A novel role for an old target: CD45 for breast cancer immunotherapy | Oncoimmunology | Annat Raiter Oran Zlotnik Julia Lipovetsky Shany Mugami Shira Dar | 2021/1/1 |
COVID-19 content collection | The Lancet | William M Souza Mariene R Amorim Renata Sesti-Costa Lais D Coimbra Natalia S Brunetti | 2021/7/7 |
Noninvasive Tracking of Natural Killer Cells Using Gold Nanoparticles | ACS Omega | Katerina Shamalov Rinat Meir Menachem Motiei Rachela Popovtzer Cyrille J Cohen | 2021/10/22 |
Combined presentation and immunogenicity analysis reveals a recurrent RAS. Q61K neoantigen in melanoma | The Journal of Clinical Investigation | Aviyah Peri Erez Greenstein Michal Alon Joy A Pai Tamir Dingjan | 2021/10/15 |
Covid-19: More young children are being infected in Israel and Italy, emerging data suggest | Michael Day | 2021/2/9 | |
Targeting glycosylated antigens on cancer cells using siglec‐7/9‐based CAR T‐cells | Molecular Carcinogenesis | Sara Meril Ortal Harush Yishai Reboh Tatyana Matikhina Tilda Barliya | 2020/5/11 |
Development and manufacturing of novel locally produced anti-BCMA CART cells for the treatment of relapsed/refractory multiple myeloma: phase I clinical results | Haematologica | Nathalie Asherie Shlomit Kfir-Erenfeld Batia Avni Miri Assayag Tatyana Dubnikov | 2020 |
Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myeloma | Haematologica | Ortal Harush Nathalie Asherie Shlomit Kfir-Erenfeld Galit Adler Tilda Barliya | 2020 |
Co-Authors
